Author | Lightnews

Drugs in Context @drugsincontext.bsky.social · 1d

💊 Multimodal treatment of pineal metastasis from oesophageal adenocarcinoma

Rifaldi et al.

@drugsincontext.bsky.social #oncology #neurology #gastroenterology #CaseReport #metastasis #tumors #MedSky #PharmSky @medsky.social @me.pharmsky.app

www.drugsincontext.com/multimodal-t...

Drugs in Context @drugsincontext.bsky.social · 4d

💊Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies

Shunyakov et al.

@drugsincontext.bsky.social #sclc #oncology
@me.pharmsky.app
www.drugsincontext.com/place-in-the...

Drugs in Context @drugsincontext.bsky.social · 11d

💊 JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review

Henriques dos Santos et al.

@drugsincontext.bsky.social #dermatology #JAKinhibitors #biologics #MedSky #PharmSky

www.drugsincontext.com/jak-inhibito...

JAK inhibitors for the treatment of palmoplantar pustulosis: a narrative review - Drugs in Context

This narrative review evaluates current evidence on the efficacy and safety of JAK inhibitors in the treatment of palmoplantar pustulosis.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Oct 2

📣Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report

Karaman et al.

@drugsincontext.bsky.social #immunology #neurology #myastheniagravis #pregnancy #pharmacology #MedSky #PharmSky

www.drugsincontext.com/management-o...

Management of refractory generalized myasthenia gravis with eculizumab during pregnancy and puerperium: a case report - Drugs in Context

This case report describes a successful pregnancy in a patient who received eculizumab for refractory generalized myasthenia gravis that was difficult to manage during the pre-pregnancy period.

www.drugsincontext.com

1

Drugs in Context @drugsincontext.bsky.social · Sep 29

📣 In vitro antimicrobial activity of an oral spray combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride

Capezzone et al.

@drugsincontext.bsky.social #antimicrobials #respiratorytractinfections #invitro #MedSky #PharmSky

www.drugsincontext.com/in-vitro-ant...

In vitro antimicrobial activity of an oral spray combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride - Drugs in Context

This study evaluates the in vitro antimicrobial activity of a new oral spray formulation combining 0.15% benzydamine hydrochloride and 0.5% cetylpyridinium chloride. In addition modified vaccinia Anka...

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Sep 26

📣 Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach

Menzella et al.

@drugsincontext.bsky.social #RespiratoryDisease #asthma #biologics #allergy
#MedSky #PharmSky

www.drugsincontext.com/tezepelumab-...

Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach - Drugs in Context

This article describes the clinical and functional evolution of a young patient with severe early-onset allergic asthma with impaired respiratory function treated with the anti-thymic stromal lymphopo...

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Sep 22

📣 10 years of real-world data: long-term efficacy and safety of HyalOne® for hip osteoarthritis

Migliore et al.

www.drugsincontext.com/10-years-of-...

@drugsincontext.bsky.social

#Osteoarthritis #Orthopedics #HipOA #LongitudinalStudy #HyaluronicAcid #Rheumatology #MedSky #PharmSky

1 1

Drugs in Context @drugsincontext.bsky.social · Sep 18

Nurses’ perceptions on the usability of the Hyrimoz® Sensoready® autoinjector device

Both et al.

www.drugsincontext.com/nurses-perce...

@drugsincontext.bsky.social

#nursing #gastroenterology #patientcare #usability #medicaldevices #PharmSky #MedSky

1

Drugs in Context @drugsincontext.bsky.social · Sep 15

Treatment of vitiligo with topical ruxolitinib: a narrative review

Monteiro e Silva et al.

Review in @drugsincontext.bsky.social on topical ruxolitinib for non-segmental vitiligo.

#MedSky #dermatology #vitiligo #biologics #smallmoleculemedication #PharmSky

www.drugsincontext.com/treatment-of...

Treatment of vitiligo with topical ruxolitinib: a narrative review - Drugs in Context

This narrative study aims to review and synthesize the current evidence on the safety, efficacy and therapeutic impact of topical ruxolitinib cream in vitiligo.

www.drugsincontext.com

1

Drugs in Context @drugsincontext.bsky.social · Sep 9

📣Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms

Dattola et al.

#drugsincontext #dermatology #psoriasis #PsoriaticArthritis #biologics #RealWorldEvidence #MedSky #PharmSky #DermSky

www.drugsincontext.com/real-world-a...

Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms - Drugs in Context

This article aims to evaluate the effect of IL-23 inhibitors on clinical outcomes and progression of PsA in patients with moderate-to-severe psoriasis and early musculoskeletal involvement.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Aug 29

Celebrating milestones and embracing innovation: the next chapter for Drugs in Context

www.drugsincontext.com/celebrating-...

@drugsincontext.bsky.social #Editorial #ImpactFactor #Publishing #OpenAccess #pharmacology #drugs #treatment #MedSky #PharmSky

Celebrating milestones and embracing innovation: the next chapter for Drugs in Context - Drugs in Context

The Senior Editors of Drugs in Context are excited to announce that the journal received its first Impact Factor of 2.8 in the 2025 Edition of Journal Citation Reports by Clarivate.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Aug 26

New publication!

Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic #asthma with or without chronic rhinosinusitis with #nasalpolyps: a real-life prospective study

Lombardi et al.

#MedSky #PharmSky
www.drugsincontext.com/dupilumab-re...

Drugs in Context @drugsincontext.bsky.social · Aug 14

New article in @drugsincontext.bsky.social

Properties and potentialities of hyaluronic acid and eXcellent Tridimensional Reticulation as a filling agent: a review

Wong & Manni

#MedSky #PharmSky #DermSky #dermatology #skinaging #hyaluronicacid #dermalfillers

www.drugsincontext.com/properties-a...

Properties and potentialities of hyaluronic acid and eXcellent Tridimensional Reticulation as a filling agent: a review - Drugs in Context

This review summarizes the most relevant novelties in the field of HA fillers, focusing on the properties and potentialities of HA and XTR™ in the treatment of skin ageing.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Jul 25

📢 New article in @drugsincontext.bsky.social

Use of safinamide for treatment of Parkinson disease: real-world data from Spain

Morales Casado and López Ariztegui

#MedSky #PharmSky #neurology #ParkinsonsDisease #geriatrics #pharmacology #RealWorldData

www.drugsincontext.com/use-of-safin...

Use of safinamide for treatment of Parkinson disease: real-world data from Spain - Drugs in Context

This article collects and reviews reports from Spanish authors presented at national and international conferences on the use of safinamide in patients with Parkinson disease.

www.drugsincontext.com

2

Drugs in Context @drugsincontext.bsky.social · Jul 24

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations

Sarah L. Anderson

@drugsincontext.bsky.social #MedSky #PharmSky #GLP1 #GLP1RA #obesity #obesitymanagement #pharmacology #clinicaltrials

www.drugsincontext.com/emerging-con...

Emerging concepts in obesity management: focus on glucagon receptor agonist combinations - Drugs in Context

This narrative review provides a comprehensive examination of the current landscape of GCGR-based combinations in phase III trials for the treatment of obesity.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Jul 17

📣 New in @drugsincontext.bsky.social

Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia

Ketsela Zeleke et al.

#MedSky #PharmSky #pharmacy #communitypharmacy

www.drugsincontext.com/simulated-cl...

Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia - Drugs in Context

This study aimed to assess the extent and factors of non-prescription dispensing of narcotic and psychotropic medications at community drug retail outlets in Ethiopia.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Jul 9

📢 New article in @drugsincontext.bsky.social

Evaluating the efficacy of #curcumin plus serratiopeptidase formulation in inflammatory #acne: a quasi-experimental study

Junaid et al.

#MedSky #PharmSky #dermatology #acne #acnevulgaris

www.drugsincontext.com/evaluating-t...

Evaluating the efficacy of curcumin plus serratiopeptidase formulation in inflammatory acne: a quasi-experimental study - Drugs in Context

This article evaluates the efficacy of a combined oral curcumin plus serratiopeptidase formulation as an adjunct to inflammatory acne therapy.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Jun 26

📣 New article in @drugsincontext.bsky.social

Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review

Lucente et al.

#MedSky #PharmSky #Ophthalmology #Pharmacology

www.drugsincontext.com/prevention-o...

Prevention of epiretinal membrane traction progression with topical indomethacin treatment: a case report and mini literature review - Drugs in Context

This article presents a case report on epiretinal membrane formation from the internal limiting membrane and examines the potential benefits of 0.5% indomethacin eye drops, supported by a brief litera...

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Jun 25

📣 New series in @drugsincontext.bsky.social

New treatment options for advanced #endometrialcarcinoma

Guest Ed: Vanda Salutari

Insights from real-world clinical experiences in Italian oncology centres

#MedSky #PharmSky #oncology #womenshealth #immunotherapy

www.drugsincontext.com/special_issu...

New treatment options for advanced endometrial carcinoma - Drugs in Context

Insights from real-world clinical experiences in Italian oncology centres.

www.drugsincontext.com

Drugs in Context @drugsincontext.bsky.social · Jun 19

🎉 Exciting News! 🎉

We are thrilled to announce that @drugsincontext.bsky.social has received its very first Clarivate JIF (2024 JIF 2.8)!

For info, please visit our webpage (www.drugsincontext.com) or email us ([email protected])

#MedKy #PharmSky #ImpactFactor #ClarivateJCR2025

Welcome to Drugs in Context - Drugs in Context

Drugs in Context is indexed in Clarivate JCR with a 2024 JIF of 2.8 Clarivate ESCI, is a member of the Directory of Open Access Journals, and is listed on

www.drugsincontext.com